KEI filing in ITC investigation 332–596, on COVID–19 Diagnostics and Therapeutics:, 20 March 2023
WTO
166 contracts disclosed in SEC filings include authorizations to use U.S. patents without consent from patent holders
On 12 October 2022, Knowledge Ecology International (KEI) published a briefing note on the U.S. federal government FAR 52.227-1 authorizations (for non voluntary use of patents) disclosed in 166 SEC exhibits. KEI Briefing Note 2022:2, Federal government FAR 52.227-1 authorizations… Continue Reading
7 July 2022: Human Rights Council adopts resolution on right to health resolution with references delinkage, solidarity, global public good, and the transfer of technology and know-how
On Thursday, 7 July 2022, the 40th session of the Human Rights Council (HRC) adopted, by consensus, a resolution on Access to medicines, vaccines and other health products in the context of the right of everyone to the enjoyment of… Continue Reading
KEI review of 62 COVID 19 contracts reveals 59 authorizations for non-voluntary use of third party patents under 28 USC 1498
Since the COVID 19 Pandemic began, there has been a spirited debate over patent rights, including a highly publicized 20 month debate over a proposed WTO waiver on intellectual property rights. During that time a handful of countries have taken… Continue Reading
Human Rights Council heats up during informal talks on inequality, international solidarity, and intellectual property
UPDATE: On Monday, 4 July 2022, a revised version of the Core Group’s access to medicines, vaccines, and other health products resolution (A/HRC/50/L.13) was circulated. The current co-sponsors include: Argentina, Brazil, China, Ecuador,* Egypt,* India, Indonesia, Malaysia, Namibia, Nepal, Paraguay,… Continue Reading
The June 17, 2022 WTO Ministerial Decision on the TRIPS Agreement
Updated Friday, 17 June 2022, 11:30 AM Geneva time. Early Friday morning, 17 June 2022, the WTO’s 12th Ministerial Conference (chaired by Timur Suleymenov, Kazakshstan), adopted a Ministerial Decision on the TRIPS Agreement (WT/MIN(22)/W/15/Rev.2). The text can be found here.… Continue Reading
PhRMA targets WHO, WIPO, WTO, UNDP, UNCTAD, Unitaid, and WTO in comments to the USTR’s Special 301 report for 2022
On 13 December 2021, the Office of United States Trade Representative (USTR) posted the following request for public comment in relation to its 2022 Special 301 Review: Identification of Countries Under Section 182 of the Trade Act of 1974 noting… Continue Reading
13 October 2021: Indonesia’s statement on the TRIPS waiver
On Wednesday, 13 October 2021, Indonesia delivered the following statement at the TRIPS Council discussions on the TRIPS waiver. PROPOSAL FOR A WAIVER FROM CERTAIN PROVISIONS OF THE TRIPS AGREEMENT FOR THE PREVENTION, CONTAINMENT AND TREATMENT OF COVID-19 Thank you,… Continue Reading
The European Union’s riposte to the WTO TRIPS waiver
Knowledge Ecology International (KEI) has obtained an document authored by the European Union which outlines a counter-proposal to the proposed TRIPS waiver. It is expected that the European Union will formally submit its counter-proposal to the World Trade Organization (WTO)… Continue Reading
WHA74: KEI’s statement on the global strategy and plan of action on public health, innovation, and intellectual property
At the World Health Organization’s 74th World Health Assembly, Knowledge Ecology International delivered the following remarks on WHO’s global strategy and plan of action on public health, innovation, and intellectual property on Saturday, 29 May 2021. Non-state actors are limited… Continue Reading